In another probe, they are looking into some individuals’ involvement in the import of a liver cancer drug ... China, according to one of the people, as Bloomberg reports. AZ in 2022 received ...

The individuals being held are all Chinese citizens who marketed cancer drugs ... patients to find drugs from outside China, sometimes through illegal channels. While China allows patients to ...

Similar signs of growth can be seen in the amount of drugs, biologics and medical devices the country exports to the US. The US FDA notes that China ranks third among countries that export drugs ...

Authorities are also looking into some of the individuals’ involvement in importing a liver cancer drug that ... That has forced patients to find drugs from outside China, sometimes through illegal ...

The plants make hundreds of critical medicines, including antibiotics, blood thinners and cancer ... and China.” “Cascade of failure” The FDA keeps a confidential list of drug facilities ...

The FDA allows and even encourages compounding ... to plug supply holes of crucial drugs like cancer medicines cisplatin, methotrexate, and 5-fluorouracil. Most compounded drugs are old, cheap ...

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug ... in China as a second-line therapy for two blood cancer ...

The individuals being held are all Chinese citizens who marketed cancer ... in China, or approved much later than in other developed nations. That has forced patients to find drugs from outside China, ...

Beijing, Sep 9 (PTI) China has announced plans ... need for China to pave the way for import of Indian cancer drugs, which were far cheaper than their western counterparts. India has been pressing ...

FDA will review PD-1 therapies, including Merck and Bristol Myers Squibb drugs, for gastric cancer treatment. Data shows PD-1 therapies benefit patients with PD-L1 levels over 10%, while those ...

The approval of Retevmo is for the treatment of advanced or metastatic medullary thyroid cancer with a RET mutation. The Food and Drug Administration (FDA) approved Retevmo (selpercatinib) for the ...